2022 Regular Session • Colorado Legislature
HB1015: Off-label Use Of Approved Drugs To Treat COVID-19
Legislative Summary
Concerning the ability of certain health-care providers to repurpose therapeutic drugs that have been approved by the federal food and drug administration for another purpose to provide treatment to individuals with COVID-19.
Bill History
1/12/2022
Introduced In House - Assigned to Health & Insurance
House of Representatives
3/16/2022
House Committee on Health & Insurance Postpone Indefinitely
House of Representatives
Roll Call Votes
House Health & Insurance: Postpone House Bill 22-1015 indefinitely using a reversal of the previous roll call. There was no objection to the use of the reverse roll call, therefore, the bill was postponed indefinitely.
3/16/2022
7
Yea
4
Nay
0
Not Voting
0
Absent
Result: PASSED
House Health & Insurance: Postpone House Bill 22-1015 indefinitely using a reversal of the previous roll call. There was no objection to the use of the reverse roll call, therefore, the bill was postponed indefinitely.
3/16/2022
7
Yea
4
Nay
0
Not Voting
0
Absent
Result: PASSED
Status Information
Current Status
Failed(3/16/2022)
Chamber
House of Representatives
Sine Die
